scispace - formally typeset
A

Anders Sönnerborg

Researcher at Karolinska Institutet

Publications -  432
Citations -  21283

Anders Sönnerborg is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Viral load & Virus. The author has an hindex of 66, co-authored 407 publications receiving 19240 citations. Previous affiliations of Anders Sönnerborg include University of Missouri & University College London.

Papers
More filters
Journal ArticleDOI

Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers

TL;DR: EC have richer gut microbiota than untreated HIV patients, with unique bacterial signatures and a distinct metabolic profile which may contribute to control of HIV.
Journal ArticleDOI

Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003–2010

TL;DR: Plasma samples from 1,463 patients newly diagnosed with HIV-1 infection between 2003 and 2010 were analyzed and showed that TDR was positively associated with men who have sex with men (MSM) and subtype B infection and negatively associated with CD4 cell counts.
Journal ArticleDOI

Indinavir-based treatment of HIV-1 infected patients: efficacy in the central nervous system.

TL;DR: It is shown that one PI, indinavir, is present in the CSF at therapeutic concentrations, and is likely to contribute to the antiretroviral activities observed within the CNS.
Journal ArticleDOI

Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection.

TL;DR: A defect in the coexpression of perforin in granzyme A-positive CD8(+) T cells in lymphoid tissue from patients with acute HIV infection and a reduction in the perforIn-dependent nuclear translocation of granzymeA are described, suggesting that mechanisms inhibiting CTL-mediated cytotoxicity are operative in lymphoids tissue early in the course of HIV infection.
Journal ArticleDOI

Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy.

TL;DR: As LPS and HMGB1 tend to form immunologically active complexes in vitro, it is proposed that such complexes may be involved in the immune activation and pathogenesis of HIV-1 infection.